News In Brief
J&J completes $19.7 billion Synthes purchase. ReVision Optics’ PresbyLens presbyopia trial update. Mindray gains controlling stake in Dragonbio. More news briefs.
J&J completes $19.7 billion Synthes purchase. ReVision Optics’ PresbyLens presbyopia trial update. Mindray gains controlling stake in Dragonbio. More news briefs.